Serial Number
79158646
Owner
SUMITOMO PHARMA CO., LTD.Attorney
Rebeccah GanFiling Date
Nov 18, 2014
SUMITOMO DAINIPPON PHARMA Trademark
Serial Number: 79158646 • Registration: 4848567
Trademark Classes
Owner Contact Info
6-8, DOSHOMACHI 2-CHOME, CHUO-KU
OSAKA-SHI, OSAKA 541-0045 , JP
Entity Type: 03
6-8, DOSHOMACHI 2-CHOME, CHUO-KU
OSAKA 541-0045 , JP
Entity Type: 03
Legal Representation
Correspondence Address
Rebeccah Gan Wenderoth LLP
1025 Connecticut Ave., N.W., Suite 500
Washington, DC 20036
UNITED STATES
Trademark Details
Filing Date
November 18, 2014
Registration Date
November 10, 2015
Published for Opposition
August 25, 2015
Cancellation Date
November 18, 2024
Goods & Services
Pharmaceutical preparations, both prescription and over-the-counter, namely, preparations for use in treating the central nervous system for use in connection with humans and animals; pharmaceutical preparations for use in treating the peripheral nervous system for use in connection with humans and animals; pharmaceutical preparations for use in treating sensory organs for use in connection with humans and animals; pharmaceutical preparations for use in treating respiratory organs for use in connection with humans and animals; pharmaceutical preparations for use in treating metabolism for use in connection with humans and animals; pharmaceutical preparations for use in treating epidermis for use in connection with humans and animals; pharmaceutical preparations for use in treating uro-genitial organs for use in connection with humans and animals; pharmaceutical preparations for use in treating digestive organs for use in connection with humans and animals; pharmaceutical preparations for use in treating cardiovascular organs for use in connection with humans and animals; antiallergic pharmaceutical preparations for use in connection with humans and animals; diagnostic pharmaceutical preparations for medical and veterinary use; antitumor pharmaceutical preparations for use in connection with humans and animals; antibiotic pharmaceutical preparations for use in connection with humans and animals; chemotherapeutic pharmaceutical preparations for use in connection with humans and animals; biological pharmaceutical preparations for the treatment of cancer for use in connection with humans and animals; immunoregulator pharmaceutical preparations for use in connection with humans and animals; pharmaceutical preparations, namely, chemical reagents for medical or veterinary purposes; diagnostic pharmaceutical preparations for medical purposes